Page 537 - AWSAR 2.0
P. 537

time. The development of medicines for non- communicable diseases, which are otherwise known as lifestyle diseases, are the talk of the town now. Hence, this research addressed the need of the hour, and the test drug fucoidan was found to be beneficial in diabetes-associated
Ms. Sathiya Ramu || 513
Alzheimer’s disease. Hence, we suggest that fucoidan, with an ample source of raw material from the sea, can be a cost-effective drug against diabetes-associated Alzheimer’s disease.
   































































































   535   536   537   538   539